Dietyloamid kwasu lizergowego (Polish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Dietyloamid kwasu lizergowego" in Polish language version.

refsWebsite
Global rank Polish rank
2nd place
6th place
4th place
7th place
1st place
1st place
924th place
75th place
3,887th place
1,274th place
43rd place
484th place
20th place
48th place
175th place
675th place
5th place
2nd place

bbc.com

doi.org

dx.doi.org

  • David J. Nutt i inni, Drug harms in the UK: a multicriteria decision analysis, „The Lancet”, 376 (9752), 2010, s. 1558–1565, DOI10.1016/S0140-6736(10)61462-6, PMID21036393 [dostęp 2024-10-01] (ang.).
  • T. Greiner, N.R. Burch, R. Edelberg, Psychopathology and psychophysiology of minimal LSD-25 dosage; a preliminary dosage-response spectrum, „A.M.A. Archives of Neurology and Psychiatry”, 79 (2), 1958, s. 208–210, DOI10.1001/archneurpsyc.1958.02340020088016, PMID13497365 [dostęp 2024-10-01] (ang.).
  • Torsten Passie i inni, The pharmacology of lysergic acid diethylamide: a review, „CNS neuroscience & therapeutics”, 14 (4), 2008, s. 295–314, DOI10.1111/j.1755-5949.2008.00059.x, PMID19040555, PMCIDPMC6494066 [dostęp 2024-10-01] (ang.).
  • H. Isbell i inni, Cross tolerance between LSD and psilocybin, „Psychopharmacologia”, 2, 1961, s. 147–159, DOI10.1007/BF00407974, PMID13717955 [dostęp 2024-10-01] (ang.).
  • A.B. Wolbach, H. Isbell, E.J. Miner, Cross tolerance between mescaline and LSD-25, with a comparison of the mescaline and LSD reactions, „Psychopharmacologia”, 3, 1962, s. 1–14, DOI10.1007/BF00413101, PMID14007904 [dostęp 2024-10-01] (ang.).
  • Matthias Forstmann i inni, Transformative experience and social connectedness mediate the mood-enhancing effects of psychedelic use in naturalistic settings, „Proceedings of the National Academy of Sciences of the United States of America”, 117 (5), 2020, s. 2338–2346, DOI10.1073/pnas.1918477117, PMID31964815, PMCIDPMC7007572 [dostęp 2024-10-01] (ang.).
  • E. Kast, Attenuation of anticipation: a therapeutic use of lysergic acid diethylamide, „The Psychiatric Quarterly”, 41 (4), 1967, s. 646–657, DOI10.1007/BF01575629, PMID4169685 [dostęp 2024-10-01] (ang.).
  • R. Andrew Sewell, John H. Halpern, Harrison G. Pope, Response of cluster headache to psilocybin and LSD, „Neurology”, 66 (12), 2006, s. 1920–1922, DOI10.1212/01.wnl.0000219761.05466.43, PMID16801660 [dostęp 2024-10-01] (ang.).
  • Brian E. McGeeney, Cannabinoids and hallucinogens for headache, „Headache”, 53 (3), 2013, s. 447–458, DOI10.1111/head.12025, PMID23278122 [dostęp 2024-10-01] (ang.).
  • Teri S. Krebs, Pål-Ørjan Johansen, Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials, „Journal of Psychopharmacology”, 26 (7), 2012, s. 994–1002, DOI10.1177/0269881112439253, PMID22406913 [dostęp 2024-10-01] (ang.).
  • Arran Frood, LSD helps to treat alcoholism, „Nature”, 2012, DOI10.1038/nature.2012.10200 (ang.).
  • Peter Gasser, Katharina Kirchner, Torsten Passie, LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: a qualitative study of acute and sustained subjective effects, „Journal of Psychopharmacology”, 29 (1), 2015, s. 57–68, DOI10.1177/0269881114555249, PMID25389218 [dostęp 2024-10-01] (ang.).

erowid.org

nih.gov

ncbi.nlm.nih.gov

  • David J. Nutt i inni, Drug harms in the UK: a multicriteria decision analysis, „The Lancet”, 376 (9752), 2010, s. 1558–1565, DOI10.1016/S0140-6736(10)61462-6, PMID21036393 [dostęp 2024-10-01] (ang.).
  • T. Greiner, N.R. Burch, R. Edelberg, Psychopathology and psychophysiology of minimal LSD-25 dosage; a preliminary dosage-response spectrum, „A.M.A. Archives of Neurology and Psychiatry”, 79 (2), 1958, s. 208–210, DOI10.1001/archneurpsyc.1958.02340020088016, PMID13497365 [dostęp 2024-10-01] (ang.).
  • Torsten Passie i inni, The pharmacology of lysergic acid diethylamide: a review, „CNS neuroscience & therapeutics”, 14 (4), 2008, s. 295–314, DOI10.1111/j.1755-5949.2008.00059.x, PMID19040555, PMCIDPMC6494066 [dostęp 2024-10-01] (ang.).
  • H. Isbell i inni, Cross tolerance between LSD and psilocybin, „Psychopharmacologia”, 2, 1961, s. 147–159, DOI10.1007/BF00407974, PMID13717955 [dostęp 2024-10-01] (ang.).
  • A.B. Wolbach, H. Isbell, E.J. Miner, Cross tolerance between mescaline and LSD-25, with a comparison of the mescaline and LSD reactions, „Psychopharmacologia”, 3, 1962, s. 1–14, DOI10.1007/BF00413101, PMID14007904 [dostęp 2024-10-01] (ang.).
  • E.A. Griggs, M. Ward, LSD toxicity: a suspected cause of death, „The Journal of the Kentucky Medical Association”, 75 (4), 1977, s. 172–173, PMID845494 [zarchiwizowane 2016-03-10] (ang.).
  • Matthias Forstmann i inni, Transformative experience and social connectedness mediate the mood-enhancing effects of psychedelic use in naturalistic settings, „Proceedings of the National Academy of Sciences of the United States of America”, 117 (5), 2020, s. 2338–2346, DOI10.1073/pnas.1918477117, PMID31964815, PMCIDPMC7007572 [dostęp 2024-10-01] (ang.).
  • E. Kast, Attenuation of anticipation: a therapeutic use of lysergic acid diethylamide, „The Psychiatric Quarterly”, 41 (4), 1967, s. 646–657, DOI10.1007/BF01575629, PMID4169685 [dostęp 2024-10-01] (ang.).
  • R. Andrew Sewell, John H. Halpern, Harrison G. Pope, Response of cluster headache to psilocybin and LSD, „Neurology”, 66 (12), 2006, s. 1920–1922, DOI10.1212/01.wnl.0000219761.05466.43, PMID16801660 [dostęp 2024-10-01] (ang.).
  • Brian E. McGeeney, Cannabinoids and hallucinogens for headache, „Headache”, 53 (3), 2013, s. 447–458, DOI10.1111/head.12025, PMID23278122 [dostęp 2024-10-01] (ang.).
  • Teri S. Krebs, Pål-Ørjan Johansen, Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials, „Journal of Psychopharmacology”, 26 (7), 2012, s. 994–1002, DOI10.1177/0269881112439253, PMID22406913 [dostęp 2024-10-01] (ang.).
  • Peter Gasser, Katharina Kirchner, Torsten Passie, LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: a qualitative study of acute and sustained subjective effects, „Journal of Psychopharmacology”, 29 (1), 2015, s. 57–68, DOI10.1177/0269881114555249, PMID25389218 [dostęp 2024-10-01] (ang.).

sigmaaldrich.com

vice.com

web.archive.org

wikidata.org

worldcat.org

  • Albert Hofmann, Krzysztof Lewandowski (tłum.), LSD... moje trudne dziecko, Warszawa: Wyd. Latawiec, 2001, ISBN 83-902659-3-1, OCLC 749509878.